• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.11% Nasdaq Up0.41%

    More On EPIX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    ESSA Pharma Inc. (EPIX)

    -NasdaqCM
    2.95 0.00(0.00%) Jun 30, 3:31PM EDT
    ProfileGet Profile for:
    ESSA Pharma Inc.
    999 West Broadway
    Suite 720
    Vancouver, BC V5Z 1K5
    Canada - Map
    Phone: 778-331-0962
    Website: http://www.essapharma.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:23

    Business Summary 

    ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on ESSA Pharma Inc.

    Key Executives 
     PayExercised
    Dr. David Ross Parkinson M.D., 66
    Chief Exec. Officer, Pres and Director
    N/AN/A
    Mr. David S. Wood MBA, CMA, 59
    Chief Financial Officer
    N/A0.00
    Dr. Raymond Andersen , 69
    Chief Technical Officer, Sec. and Director
    N/AN/A
    Dr. Marianne D. Sadar , 52
    Chief Scientific Officer and Director
    N/A0.00
    Dr. Paul A. Cossum Ph.D., 63
    Exec. VP of R&D
    N/A0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.